caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1457513715

Brian SongM.D.

OphthalmologyLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$552
Payment records
6
By payment type
Food and Beverage$552
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,721
Beneficiaries
—
Total drug cost
$241K
Distinct drugs
20
Brand share
48.8%
Top prescribed drugs
Latanoprost318 claims
Dorzolamide Hcl/Timolol Maleat291 claims
Brimonidine Tartrate213 claims
Bimatoprost147 claims
Timolol Maleate128 claims
REFERRAL NETWORK

Where Brian Song's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE GENERAL HOSPITAL CORPORATION1988
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MASSACHUSETTS EYE AND EAR INFIRMARY125608
THE GENERAL HOSPITAL CORPORATION1649
BRIGHAM & WOMENS HOSPITAL, INC.1452
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,963
Unique beneficiaries
—
Total services
2,333
Distinct HCPCS
12
Medicare payment
$131K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,144 Ophthalmology providers in CA — above median (cohort median 1,859).